# Xingnaojing for Mild-to-severe Acute Ischemic Stroke

> **NCT04150835** · PHASE4 · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 1200 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Stroke, Acute
- Stroke, Ischemic

## Interventions

- **DRUG:** Xingnaojing injection
- **DRUG:** Xingnaojing placebo injection
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT04150835
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-19
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150835, "Xingnaojing for Mild-to-severe Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04150835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*